TGTX — TG THERAPEUTICS, INC.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on TGTX
| date | signal | measured base rate |
|---|---|---|
| 2026-08-04 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-07-14 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-06-16 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-04 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-05-06 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-05-05 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-07 | Charney Laurence N Director | Gift | 500 | 0.00 | 0 |
| 2026-08-07 | Charney Laurence N Director | Gift | 450 | 0.00 | 0 |
| 2026-08-06 | Charney Laurence N Director | Gift | 5.1K | 0.00 | 0 |
| 2026-01-29 | Charney Laurence N Director | Gift | 13.2K | 0.00 | 0 |
| 2026-01-28 | Charney Laurence N Director | Gift | 30.0K | 0.00 | 0 |
| 2026-01-08 | Power Sean A CFO | Grant or award | 90.0K | 0.00 | 0 |
| 2026-01-08 | WEISS MICHAEL S CEO | Grant or award | 622.0K | 0.00 | 0 |
| 2025-11-24 | Echelard Yann Director | Open-market sale | 5.0K | 32.57 | 162.8K |
| 2025-11-05 | WEISS MICHAEL S CEO | Gift | 803.7K | 0.00 | 0 |
| 2025-11-05 | WEISS MICHAEL S CEO | Gift | 3.9M | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 739.2M | 22.3M |
| STATE STREET CORP | 287.3M | 8.6M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 274.9M | 8.3M |
| VANGUARD CAPITAL MANAGEMENT LLC | 219.4M | 6.6M |
| Soleus Capital Management, L.P. | 133.9M | 4.0M |
| GEODE CAPITAL MANAGEMENT, LLC | 116.3M | 3.5M |
| Clearbridge Investments, LLC | 106.7M | 3.2M |
| GOLDMAN SACHS GROUP INC | 76.0M | 2.3M |
| CONGRESS ASSET MANAGEMENT CO | 72.0M | 2.2M |
| JANE STREET GROUP, LLC | 67.8M | 2.0M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- MARA Holdings, Coinbase Global, Ternium And Other Big Stocks Moving Higher On Friday · 2026-08-21 · benzinga
- TG Therapeutics gains amid takeover speculation · 2026-08-21
- Why is TG Therapeutics stock rallying today? · 2026-08-21
- TG Therapeutics (TGTX) Raised Revenue Guidance After Q2, Is It Still Below Fair Value? - simplywall.st · 2026-08-14 · simplywall.st
- TG Therapeutics (TGTX) Raised Revenue Guidance After Q2, Is It Still Below Fair Value? - simplywall.st · 2026-08-14 · simplywall.st
- TG Therapeutics (TGTX) Q2 2026 Earnings Call Transcript · 2026-08-11
Ask the AI about TGTX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →